Table 1.
SZ (n = 54) | CN (n = 55) | Test statistic | p | |
---|---|---|---|---|
Age; M (SD) | 39.17 (12.41) | 39.07 (10.62) | F = 0.02 | .966 |
Male; n (%) | 19 (35.2%) | 17 (30.9%) | χ2 = 0.22 | .635 |
Personal education; M (SD) | 13.24 (2.27) | 15.4 (2.82) | F = 19.33 | < .001 |
Parental education; M (SD) | 12.9 (2.91) | 13.63 (2.85) | F = 0.21 | .647 |
Ethnicity; n (%) | χ2 = 9.16 | .103 | ||
African American | 17 (31.5%) | 16 (29.1%) | ||
Asian American | 0 | 4 (7.3%) | ||
Biracial | 3 (5.6%) | 3 (5.5%) | ||
Caucasian | 32 (59.3%) | 24 (43.6%) | ||
Hispanic/Latino | 2 (3.7%) | 6 (10.9%) | ||
Other | 0 | 2 (3.6%) | ||
Cognition; M (SD) | 39.04 (15.22) | 49.86 (10.95) | F = 17.11 | < .001 |
PANSS Positive | 13.58 (5.13) | |||
BNSS Total | 15.38 (13.47) |
Note. The SZ group consisted of 22 individuals diagnosed with schizophrenia, 29 with schizoaffective disorder, and 3 with bipolar disorder with psychotic features. Within the SZ group, 55.56% were prescribed an antipsychotic at the time of the study.